John Gribben

41PUBLICATIONS
272CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)NeonatologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Apr 22, 2026
Unfinished business in chronic lymphocytic leukemia: translational and clinical priorities for a cure.

|Apr 16, 2026
Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial.

|Mar 27, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.

Andrea Kuhnl, Amy A Kirkwood, Michael Northend

|Jul 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMT.

Simona Iacobelli, Stefan Schönland, Linda Koster

|Apr 09, 2025
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.

Fadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen

|Jul 17, 2024
Pericarditis and Cardiac Tamponade in Patients Treated with First and Second Generation Bruton Tyrosine Kinase Inhibitors: An Underappreciated Risk.

Thomas Erblich, Charlotte Manisty, John Gribben

Pageof 7

Frequent Collaborators

6 joint publications

Pedro R Cutillas

6 joint publications

Dominique Bonnet

5 joint publications

Jude Fitzgibbon

4 joint publications

Findlay Bewicke-Copley